SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPearson Regulatory News (PSON)

Share Price Information for Pearson (PSON)

Share Price is delayed by 15 minutes
Get Live Data
1,149.00    2.00 (0.17%)
Bid:
1,148.50
Ask:
1,149.00
Spread: 0.50 (0.044%)
Market Cap: £6.90b
PSON Live PriceLast checked at - London Stock Exchange

Intraday Pearson Share Chart

Disposal

7 Jun 2022 07:00

RNS Number : 9604N
Pearson PLC
07 June 2022
 

Pearson Announces Sale of Local K12 Courseware Businesses in Italy & Germany

 

LONDON, 07 JUNE 2022: In March 2021, Pearson, the world's leading learning company, announced a strategic review of its International Courseware local publishing businesses. As part of this review, Pearson already completed the disposal of its Brazilian sistemas business in October 2021 for R$789m (£108m).

 

Today, Pearson announces that it has agreed to sell its local K12 Courseware businesses in Italy and Germany to Sanoma Corporation, a leading European K12 learning services company operating in 11 countries and listed in Nasdaq Helsinki (SAA1V). The headline consideration of this transaction is £163m, which will be paid in cash on completion, subject to typical working capital adjustments. Under the terms of the transaction, Pearson will also enter into an agreement with Sanoma for it to distribute Pearson's English Language Teaching products in Italy.

 

As previously stated, the proceeds of this transaction were anticipated in the decision to commence Pearson's £350m share buyback programme, which is progressing well, with over £100m in shares repurchased since launch.

 

The Italian and German local K12 Courseware businesses had gross assets of c.£135m and net assets of c.£105m as at 31 December 2021[1].The businesses generated c.£90m of revenue and c.£9m of adjusted operating profit in 2021. The enterprise value represents an EV / 2021 EBITDA multiple of 15.5x.

 

In 2021, the businesses that are the subject of strategic review ("strategic review businesses") contributed revenue of £252m, and £22m in adjusted operating profit. The impact of disposals of strategic review businesses on Pearson's 2022 adjusted operating profit will depend upon the timing of transaction completions, but is expected to be c.£15-20m, reflecting the second half weighting of their financial contributions. Operating cash flow for these businesses is weighted to Q4 and the timing of completion is therefore also likely to impact operating cash conversion in 2022. This cash impact will be offset by the transaction working capital adjustment, recorded within cash from investing activities.

 

Pearson continues to make good progress in the remaining areas of the strategic review and will provide a further update on this in due course.

 

BNP Paribas has acted as exclusive financial adviser to Pearson plc regarding the review of its International Courseware local publishing businesses.

 

This announcement contains inside information.

 

---ENDS---

Contacts

Investor Relations 

Jo Russell 

James Caddy 

 +44 (0) 7785 451 266 

 +44 (0) 7825 948 218 

Media 

Tom Steiner 

Gemma Terry 

 +44 (0) 7787 415 891 

 +44 (0) 7841 363 216 

Teneo 

Charles Armitstead

 +44 (0) 7703 330 269 

 


[1] Gross asset value and net asset value figures are unaudited as at 31 December 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISEASKXELEAEEA
Date   Source Headline
3rd Apr 20255:24 pmRNSTransaction in Own Shares
2nd Apr 20255:28 pmRNSTransaction in Own Shares
1st Apr 20255:19 pmRNSTransaction in Own Shares
1st Apr 202510:00 amRNSTotal Voting Rights
1st Apr 20259:30 amRNSDirector/PDMR Shareholding
31st Mar 20255:21 pmRNSTransaction in Own Shares
28th Mar 20255:21 pmRNSTransaction in Own Shares
28th Mar 20251:31 pmRNSHolding(s) in Company
27th Mar 20255:16 pmRNSTransaction in Own Shares
27th Mar 202510:00 amRNSNotice of AGM
26th Mar 20255:27 pmRNSTransaction in Own Shares
25th Mar 20255:41 pmRNSTransaction in Own Shares
24th Mar 20255:18 pmRNSTransaction in Own Shares
21st Mar 20256:00 pmRNSTransaction in Own Shares
20th Mar 20255:52 pmRNSTransaction in Own Shares
19th Mar 20256:06 pmRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSAnnouncement of share repurchase programme
14th Mar 202511:56 amRNSAnnual Financial Report
14th Mar 202510:06 amRNSDirector Declaration
7th Mar 202512:00 pmRNSDirectorate Change
5th Mar 202510:08 amRNSHolding(s) in Company
3rd Mar 202510:30 amRNSTotal Voting Rights
28th Feb 20257:00 amRNSPearson 2024 Preliminary Results
3rd Feb 202511:13 amRNSDirector/PDMR Shareholding
3rd Feb 202510:45 amRNSTotal Voting Rights
24th Jan 202512:17 pmRNSDirector/PDMR Shareholding
16th Jan 20257:00 amRNSPearson 2024 Trading Statement
6th Jan 20254:07 pmRNSDirector/PDMR Shareholding
2nd Jan 202510:25 amRNSTotal Voting Rights
16th Dec 20243:50 pmRNSDirector/PDMR Shareholding
2nd Dec 20244:18 pmRNSTotal Voting Rights
2nd Dec 20244:00 pmRNSBlock listing Interim Review
1st Nov 202410:00 amRNSTotal Voting Rights
30th Oct 20241:39 pmRNSResult of AGM - Update Statement
29th Oct 20247:00 amRNSPearson 2024 Nine Month Trading Update
1st Oct 20243:50 pmRNSDirector/PDMR Shareholding
1st Oct 202411:45 amRNSTotal Voting Rights
18th Sep 20243:54 pmRNSDirector/PDMR Shareholding
5th Sep 20244:40 pmRNSBond Issue
4th Sep 20241:05 pmRNSDirector/PDMR Shareholding
2nd Sep 202412:45 pmRNSTotal Voting Rights
21st Aug 202410:42 amRNSHolding(s) in Company
9th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20244:02 pmRNSDirector Declaration
8th Aug 20244:00 pmRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
5th Aug 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.